Jean-baptiste B. Micol

Villejuif, 94805, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML.

Prognostic impact of intensive chemotherapy in patients with TP53-mutated AML.

Journal: Blood cancer journal

Published: March 10, 2026

CAR T cell-mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis.

CAR T cell-mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis.

Journal: Science translational medicine

Published: September 24, 2025

Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

Journal: Leukemia

Published: August 25, 2025

Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

Journal: Leukemia

Published: August 25, 2025

Therapy related myeloid neoplasm, same but different?

Therapy related myeloid neoplasm, same but different?

Journal: Bulletin du cancer

Published: May 13, 2025

CHIP'ing Signal from Noise in Liquid Biopsy.

CHIP'ing Signal from Noise in Liquid Biopsy.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 06, 2025

Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients.

Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients.

Journal: Blood cancer journal

Published: January 21, 2025

DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small-cell lung cancer.

DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small-cell lung cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: December 03, 2024

Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases.

Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases.

Journal: Radiology

Published: November 26, 2024

Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders.

Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 04, 2024

Dynamic changes in TP53 mutated circulating tumor DNA predicts outcome of patients with high-grade ovarian carcinomas.

Dynamic changes in TP53 mutated circulating tumor DNA predicts outcome of patients with high-grade ovarian carcinomas.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: September 23, 2024

Acute lymphoblastic leukemia in patients treated with lenalidomide for multiple myeloma: a safety meta-analysis of randomized controlled trials combined with a retrospective study of the WHO's pharmacovigilance database.

Acute lymphoblastic leukemia in patients treated with lenalidomide for multiple myeloma: a safety meta-analysis of randomized controlled trials combined with a retrospective study of the WHO's pharmacovigilance database.

Journal: Blood cancer journal

Published: July 30, 2024

Showing 1-12 of 85

Last Updated: 09/26/2026